These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 7513716)

  • 1. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.
    Bang P; Brismar K; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased ternary complex formation and predominance of a 29 kDa IGFBP-3 fragment in human fetal serum.
    Bang P; Stangenberg M; Westgren M; Rosenfeld RG
    Growth Regul; 1994 Jun; 4(2):68-76. PubMed ID: 7524886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the high molecular weight insulin-like growth factor complex in term pregnancy serum.
    Liu F; Baxter RC; Hintz RL
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1261-7. PubMed ID: 1385469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity.
    Bereket A; Lang CH; Blethen SL; Fan J; Frost RA; Wilson TA
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2282-8. PubMed ID: 7543110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
    Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I.
    Lee CY; Rechler MM
    Endocrinology; 1996 May; 137(5):2051-8. PubMed ID: 8612547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially.
    Lee CY; Rechler MM
    Endocrinology; 1995 Feb; 136(2):668-78. PubMed ID: 7530649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
    Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
    Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE; Tapanainen P; Rosenfeld RG
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis.
    Giudice LC; Dsupin BA; Gargosky SE; Rosenfeld RG; Irwin JC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1284-93. PubMed ID: 7525631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis.
    Irwin JC; Dsupin BA; Giudice LC
    J Clin Endocrinol Metab; 1995 Feb; 80(2):619-26. PubMed ID: 7531715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity.
    Fielder PJ; Thordarson G; Talamantes F; Rosenfeld RG
    Endocrinology; 1990 Nov; 127(5):2270-80. PubMed ID: 1699743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.
    Lalou C; Lassarre C; Binoux M
    Endocrinology; 1996 Aug; 137(8):3206-12. PubMed ID: 8754741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy.
    Shinada M; Akdeniz A; Panagiotopoulos S; Jerums G; Bach LA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1163-9. PubMed ID: 10720056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of cation-dependent proteases for insulin-like growth factor binding proteins does not alter the size distribution of insulin-like growth factors in pregnancy.
    Davies SC; Holly JM; Coulson VJ; Cotterill AM; Abdulla AF; Whittaker PG; Chard T; Wass JA
    Clin Endocrinol (Oxf); 1991 Jun; 34(6):501-6. PubMed ID: 1716187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
    Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy.
    Langford KS; Nicolaides KH; Jones J; Abbas A; McGregor AM; Miell JP
    J Clin Endocrinol Metab; 1995 Jan; 80(1):21-7. PubMed ID: 7530257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma.
    Lassarre C; Binoux M
    Endocrinology; 1994 Mar; 134(3):1254-62. PubMed ID: 7509737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries.
    Mason HD; Cwyfan-Hughes SC; Heinrich G; Franks S; Holly JM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):276-84. PubMed ID: 8550764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.